GENERATION BIO CO's ticker is GBIO and the CUSIP is 37148K100. A total of 78 filers reported holding GENERATION BIO CO in Q3 2023. The put-call ratio across all filers is 2.56 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $251,550 | -31.1% | 66,372 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $365,046 | +32.3% | 66,372 | +3.4% | 0.00% | 0.0% |
| Q1 2023 | $275,940 | +7.5% | 64,172 | -1.8% | 0.00% | 0.0% |
| Q4 2022 | $256,755 | -26.0% | 65,332 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $347,000 | -19.1% | 65,332 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $429,000 | -14.5% | 65,332 | -4.5% | 0.00% | 0.0% |
| Q1 2022 | $502,000 | +232.5% | 68,392 | +221.6% | 0.00% | +100.0% |
| Q4 2021 | $151,000 | -71.7% | 21,269 | -0.2% | 0.00% | -50.0% |
| Q3 2021 | $534,000 | -38.8% | 21,312 | -34.3% | 0.00% | -50.0% |
| Q2 2021 | $873,000 | -6.4% | 32,442 | -1.1% | 0.00% | 0.0% |
| Q1 2021 | $933,000 | – | 32,792 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 8,278,876 | $58,614,000 | 5.38% |
| Yiheng Capital Management, L.P. | 1,975,146 | $13,984,000 | 0.71% |
| Artal Group S.A. | 2,814,191 | $19,924,000 | 0.54% |
| HARVARD MANAGEMENT CO INC | 510,354 | $3,613,000 | 0.34% |
| Bellevue Group AG | 3,872,180 | $27,416,000 | 0.28% |
| Casdin Capital, LLC | 1,324,275 | $9,376,000 | 0.26% |
| FARALLON CAPITAL MANAGEMENT LLC | 3,500,000 | $24,780,000 | 0.12% |
| BVF INC/IL | 189,050 | $1,338,000 | 0.05% |
| PDT Partners, LLC | 36,843 | $261,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 17,739 | $126,000 | 0.02% |